Bausch & Lomb Corp (BLCO) stock
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3029% below fair value
$20.95+0.12 (+0.58%)
Close on Nov 18, 2026Market cap $7.49BP/E –Yield –
Bausch & Lomb revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Bausch & Lomb's revenue for the twelve months ending Sep 30, 2026 was $5.42B, up 8.9% year over year. For fiscal 2025 it was $5.10B, up 6.5% from the year before. The highest annual figure on record is $5.10B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.10B | +6.5% |
| FY2024 | Dec 31, 2024 | $4.79B | +15.6% |
| FY2023 | Dec 31, 2023 | $4.15B | +10.0% |
| FY2022 | Dec 31, 2022 | $3.77B | +0.1% |
| FY2021 | Dec 31, 2021 | $3.77B | +10.3% |
| FY2020 | Dec 31, 2020 | $3.41B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.38B | +7.3% |
| Q2 FY2026 | Jun 30, 2026 | $1.39B | +9.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.24B | +9.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.41B | +9.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.28B | +7.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.28B | +5.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.14B | +3.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.28B | +9.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.20B | +18.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.22B | +17.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.10B | +18.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.17B | +17.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.01B | +6.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.04B | +10.0% |
| Q1 FY2023 | Mar 31, 2023 | $931.00M | +4.7% |
| Q4 FY2022 | Dec 31, 2022 | $996.00M | -0.5% |
| Q3 FY2022 | Sep 30, 2022 | $942.00M | -0.7% |
| Q2 FY2022 | Jun 30, 2022 | $941.00M | +0.7% |
| Q1 FY2022 | Mar 31, 2022 | $889.00M | +0.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.00B | – |
| Q3 FY2021 | Sep 30, 2021 | $949.00M | – |
| Q2 FY2021 | Jun 30, 2021 | $934.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $881.00M | – |
See a number that looks wrong?